Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-28, Stock:ABBV, The news for the past five days is as follows:
2021-06-21: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: UPDATE 1-U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug.
2021-06-22: NEWS1: Invesco Canada announces cash distributions for its Canadian-listed ETFs.NEWS2: 2 Dividend Stocks That Could Be Paying You 10% Within 5 Years.
2021-06-23: nan
2021-06-24: NEWS1: AbbVie Is One Of The Biggest Pharma Companies, But Is It A Buy Right Now?.NEWS2: AbbVie Exercises Right to Acquire TeneoOne and Lead Asset TNB-383B for the Potential Treatment of Relapsed or Refractory Multiple Myeloma.
2021-06-25: NEWS1: FDA To Miss Action Dates For AbbVie's Upadacitinib Application For Psoriatic Arthritis, Ankylosing Spondylitis.NEWS2: AbbVie Provides Update Regarding RINVOQ® (upadacitinib) in Psoriatic Arthritis and Ankylosing Spondylitis in the U.S..NEWS3: 3 High-Yield Stocks With Secure Payouts.NEWS4: AbbVie Slips on FDA Delay in Arthritis-Drug Action Dates.NEWS5: AbbVie Inc. (NYSE:ABBV) is Finding Balance between Dividends and Growth.NEWS6: CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis.

Answer: Rise